Navigation Links
Clifford Chance Advises Pfizer on Conditional Clearance in China of Its Merger with Wyeth
Date:9/30/2009

NEW YORK, Sept. 30 /PRNewswire/ -- Law firm Clifford Chance, as international counsel, has advised Pfizer on the conditional clearance of its merger with Wyeth under China's Anti-Monopoly Law. The clearance was issued by the Ministry of Commerce (MOFCOM) on 29 September 2009.

Competition approval from the Chinese authorities was one of the key conditions of the Pfizer/Wyeth merger agreement.

The EU has already approved the deal; decisions are awaited from the Australian, Canadian and US competition authorities.

"The clearance is an important milestone for Pfizer's merger with Wyeth, and also tells us a lot about the continued development of China's competition procedures," said Clifford Chance's Beijing-based counsel Ninette Dodoo.

"This is the first time that the Ministry of Commerce has issued such clear conditions for the sale of competing businesses under a clearance.

"Our advice to companies seeking competition clearance is simple - establish dialogue with MOFCOM early in the process, respect its internal procedures and be responsive to its competition concerns."

The Clifford Chance team, which worked closely with Pfizer's PRC firm on the Chinese notification, included Ninette Dodoo, who relocated to Beijing from the firm's Brussels office earlier this year, partner Emma Davies in Shanghai and associates Jiajia Gao and Yang Liu in Beijing. Partner Tony Reeves in Brussels is co-ordinating the global merger notifications of Pfizer's acquisition of Wyeth outside the US, and partner Bill Blumenthal in Washington, D.C., also worked on the matter.

About Clifford Chance

Clifford Chance is one of the world's leading law firms, helping clients achieve their goals by combining the highest global standards with local expertise. The Firm has unrivalled scale and depth of legal resources across the four key markets of the Americas, Asia, Europe and the Middle East, and focuses on the core areas of commercial activity: capital markets; corporate and M&A; finance and banking; real estate; tax; pensions and employment; litigation and dispute resolution. Clifford Chance has 29 offices in 20 countries with some 3,600 legal advisers. The Firm also operates a 'best friends' arrangement with AZB & Partners in India and with Lakatos, Koves & Partners in Hungary, and a co-operation agreement with Al-Jadaan & Partners Law Firm in Saudi Arabia.

    Media Contact:
    Ashley A. Hill
    (212) 880-5638
    ashley.hill@cliffordchance.com

SOURCE Clifford Chance


'/>"/>
SOURCE Clifford Chance
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. RediClinic Offers Affordable New Plan Clinically Shown to Double a Persons Chance to Stop Smoking
2. Study Confirms That Avastin Significantly Increases Chance of Living Without Disease Progression in Metastatic Breast Cancer
3. Portable CT Increases Chance of Stroke Survival and Recovery
4. Northern California Cancer Centers First-of-Its-Kind Research Reveals Low Socioeconomic Status Often Equals Poor Chance of Lymphoma Survival
5. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
6. Kosans Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
7. Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development
8. Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
9. NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF-03187207 in Japan
10. Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug
11. MannKind Addresses Pfizers Announcement Regarding Exubera
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... 26, 2016 A key trend ... the emergence of new treatments. Cardax, a development stage ... treatment. The therapy is expected to fulfil large unmet ... is conducting studies to develop new treatments for osteoarthritis. ... genes involved in osteoarthritis are being investigated, and early ...
(Date:5/26/2016)... , May 26, 2016   Change ... and analytics, network solutions and technology-enabled services ... it entered into a strategic channel partnership ... outpatient software solutions and revenue cycle management ... hospitals and rehabilitation clinics to optimize revenue, ...
(Date:5/25/2016)... PARIS , May 25,2016 ... with the near-infrared Cellvizio platform for urological and ... MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary ... important regulatory milestone in the US with the ... Food and Drug Administration (FDA). This new FDA ...
Breaking Medicine Technology:
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... provider of comprehensive treatment for eating disorders, is opening a brand new child ... provide individuals ages 8-17 and their families with even more specialized eating disorder ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... of Mehling Orthopedics and chief medical officer of Blue Horizon International (BHI), Brian ... Regeneration. The conference was held during May 5-6, 2016 in Chicago, IL, USA. ...
(Date:5/26/2016)... ... May 26, 2016 , ... Bunion Bootie , the manufacturer of the ... more than humbled by customer demand over the Mother’s Day Weekend promotion. So much ... that Bunion Bootie has completely replenished its inventory levels, it hopes to continue its ...
(Date:5/26/2016)... ... 26, 2016 , ... The introduction of our professional athletes coincides with the ... , “We are proud to introduce Meghan Klingenberg, defender and World Champion ... Quick, wide receiver for Los Angeles who was a second round selection in the ...
(Date:5/26/2016)... ... May 26, 2016 , ... May 2016 – Lips ... central to popular cosmetic improvement efforts. Record numbers of clients now ask about lip ... or pouty, says Kally Papantoniou, MD, of Advanced Dermatology P.C. , The ...
Breaking Medicine News(10 mins):